Annual Accounts Payable
$6.33 M
-$88.00 K-1.37%
December 31, 2023
Summary
- As of February 7, 2025, VIR annual accounts payable is $6.33 million, with the most recent change of -$88.00 thousand (-1.37%) on December 31, 2023.
- During the last 3 years, VIR annual accounts payable has risen by +$1.26 million (+24.76%).
- VIR annual accounts payable is now -2.87% below its all-time high of $6.52 million, reached on December 31, 2021.
Performance
VIR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$7.30 M
+$2.92 M+66.44%
September 30, 2024
Summary
- As of February 7, 2025, VIR quarterly accounts payable is $7.30 million, with the most recent change of +$2.92 million (+66.44%) on September 30, 2024.
- Over the past year, VIR quarterly accounts payable has increased by +$2.92 million (+66.44%).
- VIR quarterly accounts payable is now -61.08% below its all-time high of $18.77 million, reached on March 31, 2020.
Performance
VIR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
VIR Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.4% | +66.4% |
| 3 y3 years | +24.8% | -39.9% |
| 5 y5 years | -2.1% | -39.9% |
VIR Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -2.9% | at low | -40.9% | +168.4% |
| 5 y | 5-year | -2.9% | +24.8% | -61.1% | +168.4% |
| alltime | all time | -2.9% | +29.3% | -61.1% | +168.4% |
Vir Biotechnology Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $7.30 M(+66.4%) |
| Jun 2024 | - | $4.39 M(-38.3%) |
| Mar 2024 | - | $7.11 M(+12.3%) |
| Dec 2023 | $6.33 M(-1.4%) | $6.33 M(+74.6%) |
| Sep 2023 | - | $3.63 M(-70.7%) |
| Jun 2023 | - | $12.36 M(+1.8%) |
| Mar 2023 | - | $12.15 M(+89.2%) |
| Dec 2022 | $6.42 M(-1.5%) | $6.42 M(+135.9%) |
| Sep 2022 | - | $2.72 M(-74.4%) |
| Jun 2022 | - | $10.62 M(-3.1%) |
| Mar 2022 | - | $10.96 M(+68.0%) |
| Dec 2021 | $6.52 M | $6.52 M(+54.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $4.22 M(-61.7%) |
| Jun 2021 | - | $11.03 M(+198.1%) |
| Mar 2021 | - | $3.70 M(-27.1%) |
| Dec 2020 | $5.08 M(-13.7%) | $5.08 M(-25.3%) |
| Sep 2020 | - | $6.80 M(+55.1%) |
| Jun 2020 | - | $4.38 M(-76.7%) |
| Mar 2020 | - | $18.77 M(+219.1%) |
| Dec 2019 | $5.88 M(-9.1%) | $5.88 M(+1.1%) |
| Sep 2019 | - | $5.82 M(+42.6%) |
| Jun 2019 | - | $4.08 M(-37.0%) |
| Dec 2018 | $6.47 M(+32.2%) | $6.47 M |
| Dec 2017 | $4.90 M | - |
FAQ
- What is Vir Biotechnology annual accounts payable?
- What is the all time high annual accounts payable for Vir Biotechnology?
- What is Vir Biotechnology annual accounts payable year-on-year change?
- What is Vir Biotechnology quarterly accounts payable?
- What is the all time high quarterly accounts payable for Vir Biotechnology?
- What is Vir Biotechnology quarterly accounts payable year-on-year change?
What is Vir Biotechnology annual accounts payable?
The current annual accounts payable of VIR is $6.33 M
What is the all time high annual accounts payable for Vir Biotechnology?
Vir Biotechnology all-time high annual accounts payable is $6.52 M
What is Vir Biotechnology annual accounts payable year-on-year change?
Over the past year, VIR annual accounts payable has changed by -$88.00 K (-1.37%)
What is Vir Biotechnology quarterly accounts payable?
The current quarterly accounts payable of VIR is $7.30 M
What is the all time high quarterly accounts payable for Vir Biotechnology?
Vir Biotechnology all-time high quarterly accounts payable is $18.77 M
What is Vir Biotechnology quarterly accounts payable year-on-year change?
Over the past year, VIR quarterly accounts payable has changed by +$2.92 M (+66.44%)